Total Synthesis of Diterpenoid Quinone Methide Tumor Inhibitor, (+)-Taxodione

An asymmetric polyene cyclization (92% ee) strategy has been successfully applied for the first asymmetric total synthesis of oxidized abietane, anticancer agent, taxodione (1) sharing a trans-decalin system. Additionally, the total syntheses of pomiferin B (2) and gaultheric acid (3) (a nor-abietane) were achieved utilizing this unified approach.

Unified short syntheses of oxygenated tricyclic aromatic diterpenes by radical cyclization with a photoredox catalyst

The biomimetic two-phase strategy employing polyene cyclization and subsequent oxidation/substitution is an effective approach for divergent syntheses of [6-6-6]-tricyclic diterpenes. However, this strategy requires lengthy sequences for syntheses of oxygenated tricyclic aromatic abietane/podocarpane diterpenes owing to the many linear oxidation/substitution steps after cyclization. Here, we present a new synthetic route based on a convergent reverse two-phase strategy employing a reverse radical cyclization approach, which enabled the unified short syntheses of four aromatic abietane/podocarpane diterpenes and the divergent short syntheses of other related diterpenes. Oxygenated and substituted precursors for cyclization were convergently prepared through Friedel-Crafts acylation and rhodium-catalyzed site-selective iodination. Radical redox cyclization using an iridium photoredox catalyst involving neophyl rearrangement furnished the thermodynamically favored 6-membered ring preferentially. (±)-5,6-Dehydrosugiol, salvinolone, crossogumerin A, and Δ5-nimbidiol were synthesized in only 8 steps. An oxygenated cyclized intermediate was also useful for divergent derivatization to sugiol, ferruginol, saprorthoquinone, cryptomeriololide, and salvinolone.

Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential

Conifers have long been recognized for their therapeutic potential in different disorders. Alkaloids, terpenes and polyphenols are the most abundant naturally occurring phytochemicals in these plants. Here, we provide an overview of the phytochemistry and related commercial products obtained from conifers. The pharmacological actions of different phytochemicals present in conifers against bacterial and fungal infections, cancer, diabetes and cardiovascular diseases are also reviewed. Data obtained from experimental and clinical studies performed to date clearly underline that such compounds exert promising antioxidant effects, being able to inhibit cell damage, cancer growth, inflammation and the onset of neurodegenerative diseases. Therefore, an attempt has been made with the intent to highlight the importance of conifer-derived extracts for pharmacological purposes, with the support of relevant in vitro and in vivo experimental data. In short, this review comprehends the information published to date related to conifers' phytochemicals and illustrates their potential role as drugs.

Traditional usage and biological activity of Plectranthus madagascariensis and its varieties: A review

ETHNOPHARMACOLOGICAL RELEVANCE

Plectranthus madagascariensis (Pers.) Benth. is an indigenous aromatic South African plant species that are traditionally used to treat various dermatological and respiratory ailments.

AIM OF THE STUDY

Three varieties of P. madagascariensis exist in South Africa, namely, Plectranthus aliciae (Codd) van Jaarsv. & T.J. Edwards, Plectranthus ramosior (Benth.) Van Jaarsv. and Plectranthus madagascariensis (Pers.) Benth var. madagascariensis. This article summarizes the documented ethnobotanical uses and research which has been conducted to date on the chemical constituents and biological effects of P. madagascariensis and its varieties. This review aimed to investigate and highlight the lack scientific reports of the potential activity of these varieties based on their traditional usage and to emphasise the need for further investigation of the benefits of P. madagascariensis and its varieties.

MATERIALS AND METHODS

Extensive database retrieval using platforms not limited to but including Google Scholar, ScienceDirect and PubMed, was performed by using keywords such as "Plectranthus madagascariensis" "Plectranthus madagascariensis var. aliciae", "Plectranthus aliciae", "Plectranthus ramosior", "Plectranthus madagascariensis var. ramosior" and "Plectranthus hirtus" In addition, relevant books and digital documentation were consulted to collect all available scientific literature to provide a comprehensive review.

RESULTS

Several studies have reported the traditional usage of P. madagascariensis for the treatment of diseases related to the respiratory system such as coughs, colds and asthma as well as dermatological disorders associated with wounds and inflammation. Whilst there are no reports on the traditional usage of P. madagascariensis varieties to treat other maladies, several other species within the genus are used in other traditional practices. Plectranthus ramosior is used as a toxin for fishing. In literature, seven major phytochemical compounds have been identified from P. madagascariensis. Its extract and essential oil contain polyphenols, abietane diterpenes and abietane diterpenes with a quinone moiety. The extracts and major chemical constituents of P. madagascariensis and its major phytochemicals have reported activity against several biological targets. Reports relating to the antibacterial activity of P. madagascariensis against microbes associated with tuberculosis and wound infections has been consistent and correlates with the documented traditional usage of the plant. Literature reported on the antibacterial activity of P. aliciae targeting bacteria associated with wound infections and lung cancer cells. No further literature reports of the biological activity of the other P. madagascariensis varieties have been found. Other noteworthy biological activities reported in the literature of P. madagascariensis and its compounds include their activities against targets of Alzheimer's disease and breast cancer, in particular. This activity is not related to the traditional usage of the plant.

CONCLUSION

Plectranthus madagascariensis and its compounds have been proven to be effective in treating a range of maladies. Based on the extensive literature on this plant, it can be concluded that numerous in vitro pharmacological activities of P. madagascariensis have been reported. However, there is a lack of information available for this species with regards to its in vivo data including both pre-clinical and clinical studies. Since the extract of P. madagascariensis and its isolated compounds have displayed noteworthy anticancer potential, we recommend further investigation of pharmacokinetic studies to be included in future research.

Diterpenoids from Plectranthus spp. as Potential Chemotherapeutic Agents via Apoptosis

Plectranthus spp. is widely known for its medicinal properties and bioactive metabolites. The cytotoxic and genotoxic properties of the four known abietane diterpenoids: 7α-Acetoxy-6β-hydroxyroyleanone (Roy), 6,7-dehydroroyleanone (Deroy), 7β,6β-dihydroxyroyleanone6 (Diroy), and Parvifloron D (Parv), isolated from P. madagascariensis (Roy, DeRoy, and Diroy) and P. ecklonii (Parv) were evaluated. The tested compounds showed cytotoxic effects against the human leukemia cell line CCRF-CEM and the lung adenocarcinoma cell line A549. All tested compounds induced apoptosis by altering the level of pro- and anti-apoptotic genes. The results show that from the tested diterpenoids, Roy and Parv demonstrated the strongest activity in both human cancer cell lines, changing the permeability mitochondrial membrane potential and reactive oxygen species (ROS) levels, and possibly inducing mtDNA or nDNA damage. In conclusion, the abietane diterpenoids tested may be used in the future as potential natural chemotherapeutic agents

Parvifloron D from Plectranthus strigosus: Cytotoxicity Screening of Plectranthus spp. Extracts

The Plectranthus genus is commonly used in traditional medicine due to its potential to treat several illnesses, including bacterial infections and cancer. As such, aiming to screen the antibacterial and cytotoxic activities of extracts, sixteen selected Plectranthus species with medicinal potential were studied. In total, 31 extracts obtained from 16 Plectranthus spp. were tested for their antibacterial and anticancer properties. Well diffusion method was used for preliminary antibacterial screening. The minimum inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values of the five most active acetonic extracts (P. aliciae, P. japonicus, P. madagascariensis var. “Lynne”, P. stylesii, and P. strigosus) were determined. After preliminary toxicity evaluation on Artemia salina L., their cytotoxic properties were assessed on three human cancer cell lines (HCT116, MCF-7, and H460). These were also selected for mechanism of resistance studies (on NCI-H460/R and DLD1-TxR cells). An identified compound—parvifloron D—was tested in a pair of sensitive and MDR-Multidrug resistance cancer cells (NCI-H460 and NCI-H460/R) and in normal bronchial fibroblasts MRC-5. The chemical composition of the most active extract was studied through high performance liquid chromatography with a diode array detector (HPLC-DAD/UV) and liquid chromatography–mass spectrometry (LC–MS). Overall, P. strigosus acetonic extract showed the strongest antimicrobial and cytotoxic potential that could be explained by the presence of parvifloron D, a highly cytotoxic diterpene. This study provides valuable information on the use of the Plectranthus genus as a source of bioactive compounds, namely P. strigosus with the potential active ingredient the parvifloron D.

Cytotoxic Activity of Royleanone Diterpenes from Plectranthus madagascariensis Benth

Cytotoxicity screenings have identified Plectranthus plants as potential sources of antitumor lead compounds. In this work, several extracts from Plectranthus madagascariensis were prepared using different solvents (acetone, methanol, and supercritical CO₂) and extraction techniques (maceration, ultrasound-assisted, and supercritical fluid extraction), and their chemical composition was detailed using high-performance liquid chromatography with a diode array detector. The cytotoxic activity of the major compounds identified, namely, rosmarinic acid (1) and abietane diterpenes 7α,6β-dihydroxyroyleanone (2), 7α-formyloxy-6β-hydroxyroyleanone (3), 7α-acetoxy-6β-hydroxyroyleanone (4), and coleon U (5), was evaluated in a battery of human cancer cell lines, including breast (MDA-MB-231, MCF-7), colon (HCT116), and lung (NCI-H460, NCI-H460/R) cancer, and also in healthy lung (MCR-5) cells. Royleanone (3) was isolated for the first time from P. madagascariensis, and its full spectroscopic characterization (proton and carbon nuclear magnetic resonance) was accomplished. A high selectivity for lung cancer cells was observed for royleanones (2, 4) with selectivity indexes of 4.3 and 3.2, respectively. The observed results combined with literature data allowed the establishment of important structure-activity relationships for substituted royleanone abietanes, such as the requirement for an electron-donating group at positions 6 and/or 7 in the abietane skeleton, and an improved cytotoxic effect for substituents with log P values between 2 and 5.

Anticancer properties of the abietane diterpene 6,7-dehydroroyleanone obtained by optimized extraction

Aim: 6,7-dehydroroyleanone (DHR) is a cytotoxic abietane present in the essential oil of Plectranthus madagascariensis. Methods/results: Different extraction parameters were tested, and its extraction optimization was accomplished with a Clevenger apparatus-based hydrodistillation. After isolation, its effect on microtubules, P-glycoprotein and caspases was assessed on several cell lines and the compound was coupled with hybrid nanoparticles. The results show that DHR does not interfere with microtubule formation, but evades the resistance mechanisms of P-glycoprotein. Strong activation of caspases-3 and -9 indicates that DHR is able to induce apoptosis by triggering the intrinsic cell death pathway. Moreover, the assembly of DHR with hybrid nanoparticles was able to potentiate the effect of DHR in cancer cells. Conclusion: DHR seems to be a promising starting material with anticancer properties to further be explored.